Related Experiment Videos

Minimizing contrast agent dose during intraarterial gadolinium-enhanced MR angiography: in vitro assessment

Ken-Pin Hwang1, Jordin D Green, Debiao Li

  • 1Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.

Abstract

Insights

Reducing contrast agent dosage for intra-arterial contrast-enhanced magnetic resonance angiography (CE-MRA) is possible. Significant signal-to-noise ratio (SNR) is maintained even with reduced injection durations.

Area of Science:

  • Radiology
  • Medical Imaging

Background:

  • Intra-arterial (IA) contrast-enhanced magnetic resonance angiography (CE-MRA) requires precise contrast agent administration.
  • Optimizing contrast agent dosage is crucial for patient safety and cost-effectiveness.

Purpose of the Study:

  • To investigate methods for minimizing contrast agent dosage in IA CE-MRA.
  • To evaluate the impact of encoding order and injection duration on image quality and signal-to-noise ratio (SNR).

Main Methods:

  • Utilized a catheter-based IA gadolinium injection in an arterial flow phantom.
  • Systematically varied blood flow rates, injection rates, and injection durations (100% to 30% of acquisition time).
  • Measured SNR in the aorta, renal artery, and common iliac artery.

Main Results:

  • No significant SNR loss was observed with 75% injection duration for all tested vessels.
  • Excellent image quality was achieved with 50% injection duration in all vessels.
  • No significant difference in SNR was found between elliptical and sequential encoding schemes.

Conclusions:

  • Contrast agent dosage for IA CE-MRA can be substantially reduced.
  • Limiting contrast injection to a portion of the acquisition time maintains diagnostic SNR.
  • Encoding order does not significantly impact SNR in this setting.

Related Concept Videos